study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
COGN-GEN-0147_01,2012,randomized controlled trial,SMD,0.3849,0.2365,0.5333,63,63,some concerns,10.1234/acetyl-l-carnitine-cogn-gen-0147-01,cognition_journal,mental_clarity,Adults with mental clarity concerns,Mild GI discomfort,8
COGN-GEN-0147_02,2013,randomized controlled trial,SMD,0.3244,0.1887,0.4601,64,69,mixed,10.1234/acetyl-l-carnitine-cogn-gen-0147-02,cognition_journal,mental_clarity,Adults with mental clarity concerns,Mild GI discomfort,8
COGN-GEN-0147_03,2014,randomized controlled trial,SMD,0.37,0.1843,0.5557,74,73,low,10.1234/acetyl-l-carnitine-cogn-gen-0147-03,cognition_journal,mental_clarity,Adults with mental clarity concerns,None reported,12
